• CD3 is composed of four protein chains, including CD3E, CD3D, CD3G, and CD3Z, which serve as critical components of the TCR/CD3 complex on T cells. The CD3 complex plays essential roles in T cell antigen recognition, signal transduction, immune activation, and T cell development.
• Cadherin 17 (CDH17) is a member of the 7D-cadherin superfamily characterized by seven cadherin repeats and a short cytoplasmic domain. CDH17 is primarily expressed in the gastrointestinal tract, especially in the small intestine and colon, where it contributes to epithelial integrity, intercellular adhesion, peptide transport, and calcium-dependent water absorption.
• In CD3EDG/CDH17 Humanized Mice, chimeric human CD3EDG genes were engineered while endogenous mouse Cd3edg genes are disrupted. In addition, the extracellular domain of mouse Cdh17 was replaced with the corresponding human CDH17 extracellular region, enabling evaluation of human-specific therapeutics targeting CDH17.
• Human CD3E was detected on T cells of homozygous CD3EDG/CDH17 Humanized Mice, while human CDH17 expression was confirmed in colon and small intestine tissues.
• This model is suitable for preclinical pharmacodynamic and toxicity studies of bispecific antibody-drug conjugates (BsADCs), T cell engagers, and other immunotherapies targeting CDH17-positive solid tumors, including colorectal cancer and gastrointestinal cancers.

Key Advantages

• Dual humanized CD3EDG and CDH17 platform
• Suitable for T cell engager and BsADC evaluation
• Supports gastrointestinal cancer immunotherapy studies
• Humanized CD3 signaling for translational immune activation studies
• Humanized CDH17 expression in gastrointestinal tissues
• Applicable for efficacy and toxicity assessment of human-specific therapeutics

Validation

• Molecular Validation: Mouse Cd3e, Cd3d, Cd3g, and Cdh17 mRNA were detectable only in wild-type C57BL/6JNifdc mice, whereas human CD3E, CD3D, CD3G, and CDH17 mRNA were detectable in homozygous CD3EDG/CDH17 Humanized Mice by RT-PCR.
• Protein Validation: Human CD3E protein was detectable on splenic and peripheral blood T cells of homozygous CD3EDG/CDH17 Humanized Mice by flow cytometry.
• Tissue Validation: Humanized CDH17 protein expression was confirmed in colon and small intestine tissues by western blot analysis.
• Histopathological Validation: IHC analysis demonstrated CDH17 expression patterns in gastrointestinal tissues of CD3EDG/CDH17 Humanized Mice.

Application

• Bispecific antibody-drug conjugate evaluation
• T cell engager efficacy studies
• Colorectal cancer research
• Gastrointestinal cancer immunotherapy
• CDH17-targeted therapeutic development
• Preclinical toxicity and pharmacodynamic studies

CD3EDG

• The chimeric human CD3EDG was expressed, while mouse Cd3edg was knocked out in CD3EDG/CDH17 humanized mice.

CDH17

• The extracellular region (except signal peptide) of mouse Cdh17 was replaced by human CDH17 extracellular region sequences in CD3EDG/CDH17 humanized mice.

Strain specific analysis of CD3EDG/CDH17 mRNA expression in wild-type C57BL/6JNifdc mice and CD3EDG/CDH17 humanized mice by RT-PCR. Colon RNA was isolated from C57BL/6JNifdc mice (+/+) and homozygous CD3EDG/CDH17 humanized mice (H/H), and then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human CD3E, CD3D, CD3G and CDH17 primers.

Strain specific CD3E expression analysis in wild-type mice and homozygous CD3EDG/CDH17 humanized mice by flow cytometry. Splenocytes (A) and blood (B) were collected from wild-type C57BL/6JNifdc (+/+) mice and homozygous CD3EDG/CDH17 humanized mice (H/H) and analyzed by flow cytometry with anti-mouse CD3E antibody (Biolegend, 100312) and anti-human CD3E antibody (BD Biosciences, 562426).

Western blot analysis of CDH17 protein expression in homozygous CD3EDG/CDH17 humanized mice. Colon and small intestine tissue lysates were collected from wild-type C57BL/6JNifdc mice (+/+) and homozygous CD3EDG/CDH17 humanized mice (H/H), and then analyzed by western blot with anti-human CDH17(abcam, ab109190) and anti-mouse CDH17 (R&D, AF8524) antibodies. 40 μg of total proteins were loaded for western blot analysis.

Immunohistochemical (IHC) analysis of CDH17 expression in wild-type C57BL/6JNifdc mice and homozygous CD3EDG/CDH17 humanized mice. Various tissues were collected from wild-type C57BL/6JNifdc mice and CD3EDG/CDH17 humanized mice and analyzed by IHC with anti-CDH17 antibody (abcam, ab109190).

Q1：What are CD3EDG/CDH17 Humanized Mice?

CD3EDG/CDH17 Humanized Mice are genetically engineered mice expressing humanized CD3EDG and CDH17 targets for translational immunotherapy and cancer research.

Q2: Why is CDH17 an important therapeutic target?

CDH17 is highly expressed in gastrointestinal cancers and plays important roles in epithelial integrity and tumor biology, making it a promising target for cancer therapeutics.

Q3: Can these mice be used for bispecific antibody evaluation?

Yes. The model is specifically designed for evaluation of BsADCs, T cell engagers, and other human-specific CDH17-targeted therapeutics.

Q4: What tissues express humanized CDH17 in this model?

Humanized CDH17 expression was confirmed in colon and small intestine tissues.

Q5: Are these mice suitable for toxicity studies?

Yes. The model supports both efficacy and toxicity assessment of CDH17-targeted immunotherapies in vivo.